Skip to content

Comparison of Combination Antibiotics Eyedrop to Artificial Tear in Hordeolum After Incision and Curettage

Dose Antibiotic Need in Hordeolum After Incision and Curettage? : A Randomized, Placebo-controlled Trial

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00534391
Enrollment
120
Registered
2007-09-24
Start date
2007-09-30
Completion date
2008-12-31
Last updated
2010-11-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hordeolum

Keywords

Antibiotics, hordeolum

Brief summary

To compare the effectiveness of combined antibiotic ophthalmic solution (neomycin sulfate, polymyxin B sulfate and gramicidin) with placebo (artificial tear) in the treatment of hordeolum after incision and curettage

Detailed description

Hordeolum is a common eyelid disease. In case of mass, I&C is required but role of antibiotic after I&C is not clear. It may not need in post drainage period.

Interventions

DRUGneomycin sulfate, polymyxin B sulfate and gramicidin

to the effected eye 4 times a day

4 times daily

Sponsors

Chulalongkorn University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* at least 5-millimeters hordeolum * the onset within 7 days

Exclusion criteria

* previous incision and curettage of the same site within 1 month or more than 3 times * lesions in the adjacent areas suggesting of complications associated with hordeolum such as preseptal cellulitis or blepharitis * The patients with immunodeficiency, history of bleeding tendency * allergy to aminoglycoside, polymyxin B, gramicidin, xylocaine and povidone iodine

Design outcomes

Primary

MeasureTime frame
Pain scale1,3,7 days after treatment

Secondary

MeasureTime frame
Mass size and duration of cure1, 3, 7, 30 days after treatment

Countries

Thailand

Contacts

Primary ContactParima Hirunwiwatkul, MD
parima.H@chula.ac.th662-2564142
Backup ContactPuangphet Chalermphanich, MD
puangphet_c@yahoo.com662-2564142

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026